Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 16, Issue 4, 2013, Pages 191-196

  Wang, Zhaofeng ^a   Liu, Hongbing ^a   Zhao, Rende ^b   Zhang, He ^a   Liu, Chunhua ^a   Song, Yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Xintai Municipal People's Hosital of Shandong Province ^*  (China)

Author keywords

Lung neoplasms; Prognosis; TSR

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; STROMA;

EID: 84925126303     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2013.04.04     Document Type: Article

References (22)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin, 2012, 62(1): 10-29.
2. Luo Y, Feng FY, Yao J, et al. The survival and prognosis in patients with nonsmall cell lung cancer after radical surgery (A report of 231 cases). Zhongguo Zhong Liu Lin Chuang, 2005, 32(2): 92-94.
3. Gao W, Wang BC, Di JS, et al. Cox regression analysis of the prognosis of NSCLC. Zhong Liu Yan Jiu Yu Lin Chuang, 2003, 15(2): 91-93.
4. Wu YL, Huang ZF, Rong TH, et al. Post-operative staging and survival based on the revised TNM staging system for non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi, 1999(5): 363-365.
5. Sawabata N, Keller SM, Matsumura A, et al. The impact of residual multilevel N2 disease after induction therapy for non-small cell lung cancer. Lung Cancer, 2003, 42(1): 69-77.
6. Tsai CH, Lin CM, Hsieh CC, et al. Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg, 2006, 54(8): 537-543.
7. Mesker WE, Junggeburt JM, Szuhai K, et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol, 2007, 29(5): 387-398.
8. de Kruijf EM, van Nes JG, van de Velde CJ, et al. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat, 2011, 125(3): 687-696.
9. Courrech Staal EF, Wouters MW, van Sandick JW, et al. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy? Eur J Cancer, 2010, 46(4): 720-728.
10. Mesker WE, Liefers GJ, Junggeburt JM, et al. Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol, 2009, 31(3): 169-178.
11. Wang K, Ma W, Wang J, et al. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol, 2012, 7(9): 1457-1461.
12. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer, 2001, 1(1): 46-54.
13. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell, 2009, 139(5): 871-890.
14. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science, 2011, 331(6024): 1559-1564.
15. Rønnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev, 1996, 76(1): 69-125.
16. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res, 2003, 5(3): 130-135.
17. Powell DW. Myofibroblasts: paracrine cells important in health and disease. Trans Am Clin Climatol Assoc, 2000, 111: 271-293.
18. Lorusso G, Rüegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol, 2008, 130(6): 1091-1103.
19. Massagué J. TGFbeta in cancer. Cell, 2008, 134(2): 215-230.
20. Rodemann HP, Müller GA. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis, 1991, 17(6): 684-686.
21. Olaso E, Santisteban A, Bidaurrazaga J, et al. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology, 1997, 26(3): 634-642.
22. Balsamo M, Scordamaglia F, Pietra G, et al. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci USA, 2009, 106(49): 20847-20852.